Wernicke Encephalopathy: Comprehensive Guide for US Paramedics

General Condition and Pathophysiology

Wernicke encephalopathy (WE) is an acute, life-threatening neurological emergency caused by thiamine (vitamin B1) deficiency that results in reversible brain damage if treated immediately—but progresses to permanent memory loss (Korsakoff syndrome) or death if delayed. 1, 2

Pathological Changes

The brain damage occurs because thiamine is essential for glucose metabolism in neurons. Without adequate thiamine:

Mammillary bodies (memory structures) undergo hemorrhagic necrosis and atrophy
Thalamus (sensory relay center) develops symmetrical lesions and micro-hemorrhages
Periaqueductal gray matter (eye movement control) shows tissue breakdown
Cerebellum (coordination center) experiences neuronal death
Hippocampus (memory formation) sustains damage leading to permanent amnesia 3

These changes occur because thiamine reserves deplete within 20 days of inadequate intake, and the brain's high metabolic demand makes it particularly vulnerable 1.

Pertinent History and Demographics

High-Risk Populations

Chronic alcohol use disorder is the classic presentation, but WE increasingly occurs in:

Malnutrition/homelessness (poor dietary intake)
Hyperemesis gravidarum (persistent vomiting in pregnancy)
Post-bariatric surgery patients (malabsorption)
Cancer patients (increased metabolic demands, poor intake)
Chronic diuretic therapy (increased renal thiamine losses)
Dialysis patients (thiamine removed during treatment)
Post-GI surgery (malabsorption, vomiting) 1, 4

Why These Demographics Align

These populations share common mechanisms:

Decreased intake (alcoholics replace food with alcohol; cancer/surgery patients can't eat)
Increased losses (vomiting, diarrhea, dialysis)
Malabsorption (alcohol damages gut lining; surgical resections)
Increased metabolic demand (pregnancy, critical illness, refeeding) 1

Critical pitfall: Alcohol-related WE patients have particularly poor gut absorption, requiring higher IV doses 1.

Major Signs and Symptoms

The Classic Triad (Present in MINORITY of Cases)

Only 10-16% of patients present with all three:

Confusion/altered mental status (apathy, disorientation, decreased short-term memory)
Ophthalmoplegia or nystagmus (eye movement paralysis, involuntary eye movements)
Ataxia (wide-based gait, inability to walk) 5, 6

Atypical Presentations (MAJORITY of Cases)

Isolated confusion without eye or gait findings
Coma (17% mortality if untreated) 5
Hypothermia (temperature dysregulation)
Cognitive deficits (executive dysfunction, memory problems)
Polyneuropathy (numbness, weakness in extremities)
Cardiovascular symptoms (tachycardia, hypotension from "wet beriberi") 1, 4

Critical warning: Sedation, intubation, or critical illness masks neurological signs—maintain high suspicion 7.

EMS Assessment Findings

Early Assessment Findings (Scene Size-Up Through Primary Survey)

Scene clues:

Empty alcohol bottles, evidence of chronic alcohol use
Malnourished appearance, poor living conditions
Medication bottles (diuretics, chemotherapy)
Recent surgery scars (bariatric, GI procedures)

Primary survey:

Airway: May be patent but patient unable to protect if severely altered
Breathing: Often normal rate but may be shallow if obtunded
Circulation: Tachycardia common; hypotension if concurrent wet beriberi
Disability: GCS typically 8-13 (confused but responsive to verbal/painful stimuli)
Temperature: May be hypothermic 5

Neurological quick-checks:

Eye movements: Ask patient to follow your finger—look for inability to move eyes laterally (abducens palsy) or vertical gaze palsy
Nystagmus: Rapid involuntary eye movements, especially horizontal
Gait: If safe to assess, patient cannot walk heel-to-toe or has wide-based staggering gait
Mental status: Disoriented to time/place; cannot recall recent events; apathetic responses

Late/Severe Assessment Findings

If WE progresses untreated:

GCS ≤8 requiring airway management
Unresponsive to verbal stimuli
Fixed gaze deviation (complete ophthalmoplegia)
Unable to stand (complete ataxia)
Seizures (rare but possible)
Cardiovascular collapse (if concurrent wet beriberi with heart failure) 5, 6

Differentiation from Major Signs/Symptoms

Assessment findings are what YOU observe and measure (vital signs, GCS, pupil response, gait testing).

Signs and symptoms are the clinical manifestations (confusion, eye paralysis, ataxia) that you're looking FOR through your assessment.

EMS Management and Treatment Protocol

Scene to Facility Transfer Algorithm

1. Scene Size-Up and Initial Contact (0-2 minutes)

Identify high-risk factors: alcohol bottles, malnutrition, recent surgery
Note environmental clues suggesting chronic illness

2. Primary Survey (2-5 minutes)

Airway: Position for patency; prepare for advanced airway if GCS ≤8
Breathing: Apply oxygen to maintain SpO2 >94%
Circulation: Establish large-bore IV access (18g or larger)
Disability: Rapid GCS, pupil check, blood glucose
Exposure: Check for surgical scars, signs of malnutrition

3. Critical Decision Point: Blood Glucose Check

DO NOT GIVE DEXTROSE BEFORE THIAMINE if patient has risk factors for WE 5.

If blood glucose <60 mg/dL AND patient has WE risk factors:

Give thiamine 500 mg IV FIRST
Then give dextrose (D10 or D50)
Rationale: Dextrose without thiamine can precipitate acute WE or worsen existing WE by depleting remaining thiamine stores 1, 5

If blood glucose normal but altered mental status with WE risk factors:

Give thiamine 500 mg IV empirically
Do not wait for hospital confirmation 1

4. Thiamine Administration Protocol

Dose: 500 mg IV (some protocols use 100-250 mg, but 500 mg is recommended for suspected encephalopathy) 1, 8

Preparation:

Dilute in 100 mL normal saline
Administer over 30 minutes (can give faster in critical situations)
Monitor for rare anaphylaxis (flushing, hypotension, bronchospasm) 1

Route priority:

IV preferred (IM absorption poor, especially in alcoholics) 1
IO acceptable if IV access difficult
Never oral in acute setting (poor absorption, too slow)

5. Secondary Survey and Ongoing Assessment

Neurological monitoring:

Reassess GCS every 5 minutes
Document eye movement changes (improvement may occur within minutes to hours) 8
Monitor for seizure activity

Cardiovascular monitoring:

Continuous cardiac monitoring (thiamine deficiency can cause arrhythmias)
Serial vital signs every 5 minutes if unstable
Watch for signs of heart failure (wet beriberi): JVD, crackles, peripheral edema

6. Additional Medications

Magnesium sulfate: Consider 2 g IV over 15 minutes

Rationale: Magnesium is essential cofactor for thiamine-dependent enzymes
Chronic alcoholics are often magnesium-depleted
Thiamine may not work effectively without adequate magnesium 9

Avoid sedatives/benzodiazepines unless actively seizing—will worsen mental status assessment

7. Transport Decision

ALWAYS TRANSPORT to emergency department:

WE requires hospital admission for multi-day high-dose thiamine therapy
Risk of progression to permanent Korsakoff syndrome
Need for MRI confirmation and nutritional assessment 6, 10

Transport mode:

ALS transport required
Lights/sirens if GCS ≤12 or declining mental status
Notify receiving facility of suspected WE for expedited workup

8. En Route Management

Continue oxygen therapy
Maintain IV access with normal saline at KVO (keep vein open) rate
Reassess neurological status every 5 minutes
Be prepared for airway management if mental status declines
Document exact time of thiamine administration (critical for hospital team)

9. Hospital Handoff

Report must include:

"Suspected Wernicke encephalopathy based on [alcohol use/malnutrition/recent surgery] and [confusion/eye findings/ataxia]"
Exact dose and time of thiamine administration
Initial and current GCS
Blood glucose and whether dextrose was given
Any response to thiamine (even subtle improvement is significant)

On-Scene vs. Transport Considerations

Reasons TO Transport (All Cases)

There is NO scenario where you do not transport suspected WE:

Untreated WE has 17% mortality 5
Requires days of IV thiamine (not single dose)
Needs MRI for confirmation 7, 3
Risk of permanent brain damage increases with every hour of delay 6

Scene Time Goals

<10 minutes for stable patients with suspected WE
<5 minutes for GCS ≤12 or rapidly declining mental status
Do not delay transport for thiamine administration—can give en route if IV access difficult

ABCs and Medication Management

Airway Management

Indications for advanced airway:

GCS ≤8
Inability to protect airway (absent gag reflex)
Respiratory failure
Anticipated clinical decline during transport

Technique considerations:

Use video laryngoscopy if available
Avoid excessive sedation (worsens neurological assessment)
Give thiamine BEFORE intubation if possible (even 1-2 minutes can matter)

Breathing Management

Supplemental oxygen to maintain SpO2 >94%
Assist ventilations if respiratory rate <10 or >30
Capnography monitoring (target ETCO2 35-45 mmHg)

Circulation Management

Fluid resuscitation:

Normal saline preferred (avoid dextrose-containing fluids until thiamine given)
Bolus 500 mL if hypotensive
Maintain systolic BP >90 mmHg

Cardiac monitoring:

Watch for arrhythmias (thiamine deficiency affects cardiac conduction)
Tachycardia common (may improve with thiamine)

Medication Summary for Paramedics

Primary medication: Thiamine (Vitamin B1)

Indications:

Suspected or confirmed WE
Altered mental status + alcohol use disorder
Altered mental status + malnutrition
Before giving dextrose to any at-risk patient 2

Contraindications:

Known anaphylaxis to thiamine (extremely rare)
No absolute contraindications otherwise 1

Dose:

500 mg IV for suspected encephalopathy 1, 8
Alternative: 100-250 mg IV if 500 mg not available (but less optimal) 1

Administration:

Dilute in 50-100 mL normal saline
Infuse over 30 minutes (can give faster if critical)
Can repeat dose if no improvement after 30 minutes

Pharmacokinetics:

Onset: 30 minutes to 2 hours for neurological improvement 8
Peak effect: 2-4 hours
Duration: Requires multi-day therapy (single dose insufficient)
Metabolism: Phosphorylated to active form (thiamine diphosphate) in liver
Excretion: Excess excreted in urine (cannot overdose) 1, 2

Pharmacodynamics:

Acts as coenzyme for glucose metabolism enzymes
Enables neurons to produce ATP from glucose
Prevents further neuronal damage and allows recovery of reversibly damaged cells 9

Adverse effects:

Anaphylaxis (rare: <1:250,000 doses) 1
Nausea (doses >400 mg)
Mild ataxia (doses >400 mg)
Local irritation at IV site

Adjunct medication: Magnesium Sulfate

Dose: 2 g IV over 15 minutes

Rationale: Required cofactor for thiamine utilization; alcoholics often deficient 9

Chronic Condition Considerations

Is WE Chronic?

WE itself is ACUTE, but it can progress to chronic Korsakoff syndrome if untreated—a permanent dementia with irreversible memory loss 6, 10.

Medications Patients May Already Be Taking

If patient has history of WE or Korsakoff syndrome:

1. Thiamine (oral maintenance)

Dose: 50-100 mg daily 1
Purpose: Prevent recurrence in high-risk patients
Indications: History of WE, chronic alcohol use disorder, malabsorption syndromes
Contraindications: None
Pharmacokinetics: Oral absorption poor in alcoholics (only 5-10% absorbed); better in non-alcoholics
Pharmacodynamics: Maintains adequate thiamine stores to prevent deficiency

2. Multivitamins

Often prescribed for general nutritional deficiency
Usually contain 1.5-3 mg thiamine (insufficient for treatment, adequate for prevention in healthy individuals)

3. Diuretics (if patient has heart failure from wet beriberi)

Furosemide (Lasix): 20-80 mg daily
Note: Chronic diuretic use INCREASES thiamine deficiency risk (increases renal losses) 1
Patients on chronic diuretics should receive thiamine 50 mg daily prophylaxis 1

4. Medications for alcohol use disorder (if applicable)

Naltrexone: Opioid antagonist reducing alcohol cravings
Acamprosate: Reduces alcohol withdrawal symptoms
Disulfiram (Antabuse): Causes severe reaction if alcohol consumed
These don't directly relate to WE but indicate chronic alcohol use disorder

5. Psychiatric medications (if Korsakoff syndrome developed)

Antipsychotics for behavioral disturbances
Antidepressants for mood symptoms
These treat complications, not the underlying condition

Complications of Untreated WE

Acute Complications (Hours to Days)

1. Death (17% mortality if untreated) 5

Mechanism: Brainstem lesions affecting respiratory/cardiac centers
Timeline: Can occur within 24-48 hours

2. Progression to coma

Mechanism: Widespread thalamic and brainstem damage
Timeline: Hours to days
Requires intubation and ICU care 7

3. Cardiovascular collapse

Mechanism: Concurrent wet beriberi (thiamine-deficiency cardiomyopathy)
Presents as acute heart failure, shock
Timeline: Can be concurrent with neurological symptoms 1

4. Aspiration pneumonia

Mechanism: Impaired consciousness, loss of protective reflexes
Common in patients with severe confusion or coma

Chronic Complications (Days to Weeks)

5. Korsakoff Syndrome (80% of untreated WE cases) 6, 10

Irreversible anterograde amnesia (cannot form new memories)
Confabulation (fabricating memories to fill gaps)
Personality changes (apathy, lack of insight)
Mechanism: Permanent destruction of mammillary bodies and thalamus
Timeline: Develops if thiamine not given within 24-72 hours
This is the most devastating complication—patients require lifelong supervised care

6. Persistent ataxia

Mechanism: Cerebellar damage
May improve partially but often leaves permanent gait disturbance

7. Persistent ophthalmoplegia

Mechanism: Cranial nerve damage (III, IV, VI)
Usually improves with treatment but may leave residual nystagmus

How Complications Develop

Pathophysiological cascade:

Thiamine depletion (20 days of inadequate intake) 1
Impaired glucose metabolism in high-demand brain regions
Lactic acidosis in neurons (cannot complete aerobic metabolism) 1
Cellular energy failure (ATP depletion)
Excitotoxicity (glutamate accumulation damages neurons)
Vasogenic edema (blood-brain barrier breakdown)
Hemorrhagic necrosis (blood vessel rupture in affected areas)
Neuronal death (irreversible if >72 hours) 3

Critical window: The first 24-72 hours determine whether damage is reversible. Every hour without thiamine increases the risk of permanent Korsakoff syndrome 6, 10.

Key Pitfalls to Avoid

Never give dextrose before thiamine in at-risk patients 5
Don't wait for classic triad—most patients don't have it 4
Don't assume only alcoholics get WE—consider malnutrition, surgery, cancer 4
Don't use oral thiamine in acute setting—absorption too poor 1
Don't underdose—100 mg may be insufficient; use 500 mg for encephalopathy 1, 8
Don't delay transport waiting for thiamine effect—needs hospital admission 10
Don't forget magnesium—thiamine won't work without it 9

Have a follow-up question?